Literature DB >> 2917180

Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes.

S P Cai1, C A Chang, J Z Zhang, R K Saiki, H A Erlich, Y W Kan.   

Abstract

We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for beta thalassemia is a viable approach in many parts of the world where this disease is common.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917180

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Carrier detection and prenatal diagnosis of alpha-thalassemia of Southeast Asian deletion by polymerase chain reaction.

Authors:  T M Ko; L H Tseng; F J Hsieh; P M Hsu; T Y Lee
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

2.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  Identification of the multiple beta-thalassemia mutations by denaturing gradient gel electrophoresis.

Authors:  S P Cai; Y W Kan
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  A new TATA box mutation detected at prenatal diagnosis for beta-thalassemia.

Authors:  S P Cai; J Z Zhang; M Doherty; Y W Kan
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

Review 5.  Preimplantation diagnosis.

Authors:  J D Goldberg; M C Martin; R V Lebo; R A Pedersen
Journal:  West J Med       Date:  1993-09

6.  A rapid and simple electrophoretic method for the detection of mutations involving small insertion or deletion: application to beta-thalassemia.

Authors:  S P Cai; B Eng; Y W Kan; D H Chui
Journal:  Hum Genet       Date:  1991-10       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.